Mergers & Acquisitions

Onkos is expanding its musculoskeletal oncology portfolio with the JTS device to treat pediatric bone cancer....

In2Bones' product portfolio includes implants, fracture systems, biologics and related hardware to treat upper and lower extremities....

The move allows Medartis to further accelerate its U.S. extremities business....

ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis....

The move will expand Isto's portfolio of procedure-specific allografts for spine, orthopedic and sports medicine applications....

The move expands OrthoPediatrics' portfolio with a patented, non-operative solution for the treatment of clubfoot....

The decision follows FDA's recent premarket approval of CartiHeal’s Agili-C implant for the treatment of osteoarthritis....

CUPTIMIZE Hip-Spine Analysis is an x-ray based digital solution that uses patient-specific data to help surgeons assess dislocation risk....

CrossRoads is a designer and manufacturer of procedure-specific, sterile-packed implants and instruments for elective foot and ankle surgery....

M&A transactions increased every year between 2017 and 2020 but slowed considerably in 2021 due to inflated valuations and market...